The New Pharmacotherapy of Schizophrenia

Author:   Alan Breier
Publisher:   American Psychiatric Association Publishing
Volume:   v. 33
ISBN:  

9780880484916


Pages:   272
Publication Date:   01 March 1996
Format:   Hardback
Availability:   Awaiting stock   Availability explained


Our Price $213.84 Quantity:  
Add to Cart

Share |

The New Pharmacotherapy of Schizophrenia


Add your own review!

Overview

Full Product Details

Author:   Alan Breier
Publisher:   American Psychiatric Association Publishing
Imprint:   American Psychiatric Press Inc.
Volume:   v. 33
Dimensions:   Width: 14.60cm , Height: 2.50cm , Length: 22.20cm
Weight:   0.431kg
ISBN:  

9780880484916


ISBN 10:   0880484918
Pages:   272
Publication Date:   01 March 1996
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   Awaiting stock   Availability explained

Table of Contents

Reviews

The New Pharmacotherapy of Schizophrenia is a highly credible guide to pharmacotherapy of schizophrenia beyond neuroleptic drugs. This book provides mental health clinicians and informed lay readers with up-to-date information on the many drugs applicable to schizophrenia--plus a guide to anticipated new treatments. -- William T. Carpenter Jr., M.D., Director, Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland


<p> The New Pharmacotherapy of Schizophrenia is a highly credible guide to pharmacotherapy of schizophrenia beyond neuroleptic drugs. This book provides mental health clinicians and informed lay readers with up-to-date information on the many drugs applicable to schizophrenia--plus a guide to anticipated new treatments. -- William T. Carpenter Jr., M.D., Director, Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland


Author Information

Alan Breier, M.D., is Chief of the Section on Clinical Studies, Experimental Therapeutics Branch, at the National Institute of Mental Health in Bethesda, Maryland. Dr. Breier is the recipient of several awards, including the A. E. Bennett Award for Clinical Research and the Lustman Research Award. He has published more than 100 scientific papers and is a frequent national and international lecturer. Dr. Breier s main clinical and research interest is the cause and treatment of schizophrenia.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List